GEP-NET
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (NCT05364944) | Debiopharm International SA | 2022-05-18 |
| 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET (NCT05448157) | European Institute of Oncology | 2022-05-12 |
| Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (NCT05477576) | RayzeBio, Inc. | 2022-03-24 |
Track GEP-NET automatically
Every clearance here is in the API, with alerts when new ones post.